simvastatin and fibrin
simvastatin has been researched along with fibrin in 7 studies
Research
Studies (7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Midwood, KS; Schwarzbauer, JE | 1 |
| Gu, X; Masters, KS; Monzack, EL | 1 |
| Gorkiewicz-Kot, I; Kaczmarek, P; Rzeszutko, M; Skucha, W; Sladek, K; Stepien, E; Tracz, W; Undas, A | 1 |
| Karska-Basta, I; Kubicka-Trząska, A; Romanowska-Dixon, B; Undas, A | 1 |
| Qi, Z; Yang, X; Yu, P | 1 |
| Raafat, SN | 1 |
| Arnaboldi, F; Bitto, N; Colombo, M; Denti, L; Dondossola, D; Gagliano, N; La Mura, V; Latini, R; Liguori, E; Peyvandi, F; Procacci, P; Ristagno, G; Salerno, F; Sartori, P; Tripodi, A | 1 |
Trials
1 trial(s) available for simvastatin and fibrin
| Article | Year |
|---|---|
Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease. Beneficial effects of simvastatin treatment.
Topics: Aged; Blood Coagulation; Case-Control Studies; Female; Fibrin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Microscopy, Electron, Scanning; Middle Aged; Pulmonary Disease, Chronic Obstructive; Simvastatin; Thrombosis | 2009 |
Other Studies
6 other study(ies) available for simvastatin and fibrin
| Article | Year |
|---|---|
Tenascin-C modulates matrix contraction via focal adhesion kinase- and Rho-mediated signaling pathways.
Topics: 3T3 Cells; ADP Ribose Transferases; Amides; Animals; Botulinum Toxins; Cytoskeletal Proteins; Enzyme Inhibitors; Extracellular Matrix; Fibrin; Fibroblasts; Fibronectins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Focal Adhesions; Humans; Mice; Microscopy, Fluorescence; Phosphorylation; Protein-Tyrosine Kinases; Pyridines; Rats; Recombinant Proteins; rhoA GTP-Binding Protein; Signal Transduction; Simvastatin; Stress Fibers; Tenascin; Vinculin; Wound Healing | 2002 |
Efficacy of simvastatin treatment of valvular interstitial cells varies with the extracellular environment.
Topics: Animals; Aortic Valve; Calcinosis; Cell Culture Techniques; Cells, Cultured; Collagen; Dose-Response Relationship, Drug; Extracellular Matrix; Fibrin; Gels; Heart Valve Diseases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Laminin; Mevalonic Acid; Polystyrenes; rho-Associated Kinases; Simvastatin; Swine; Time Factors; Transforming Growth Factor beta1 | 2009 |
Altered fibrin clot properties in patients with retinal vein occlusion.
Topics: C-Reactive Protein; Coronary Artery Disease; Female; Fenofibrate; Fibrin; Fibrinolysis; Heptanoic Acids; Homocysteine; Humans; Hypersensitivity, Immediate; Laser Coagulation; Lipoprotein(a); Male; Pyrroles; Retinal Vein; Retinal Vein Occlusion; Simvastatin; Tetrahydroisoquinolines; Thrombosis; Venous Thromboembolism; Venous Thrombosis | 2011 |
Letter to the editor: The sole and combined effect of simvastatin and platelet rich fibrin as a filling material in induced bone defect in tibia of albino rats.
Topics: Animals; Bone Regeneration; Fibrin; Platelet-Rich Fibrin; Rats; Simvastatin; Tibia | 2019 |
Response to: Letter to the editor: The sole and combined effect of simvastatin and platelet rich fibrin as a filling material in induced bone defect in tibia of albino rats.
Topics: Animals; Bone Regeneration; Fibrin; Platelet-Rich Fibrin; Rats; Simvastatin; Tibia | 2019 |
Simvastatin Prevents Liver Microthrombosis and Sepsis Induced Coagulopathy in a Rat Model of Endotoxemia.
Topics: Animals; Disease Models, Animal; Endothelial Cells; Endotoxemia; Fibrin; Hemostatics; Lipopolysaccharides; Liver Diseases; Male; Necrosis; Rats; Rats, Wistar; Sepsis; Simvastatin; Thrombosis; von Willebrand Factor | 2022 |